Scientists make advances in stem-cell-based liver toxicity testing
This article was originally published in Scrip
Executive Summary
A research project involving scientists in the UK and the US has produced liver cells from induced pluripotent stem cells (iPSC) for use in drug toxicity testing. One of the partners in the project, the MRC's Scottish Centre for Regenerative Medicine, is looking to set up a collaboration with researchers in China who recently achieved a similar success.